The Geriatric Nutritional Risk Index Predicts Tolerability of Lenvatinib in Patients With Hepatocellular Carcinoma
Akiyoshi Kinoshita(The Jikei University Hospital), Masayuki Saruta, Noriko Hagiwara(The Jikei University Hospital), Tsunekazu Oikawa(University of North Carolina at Chapel Hill), Kazuhiko Koike(Kanto Central Hospital), Akiyuki Osawa(The Jikei University Hospital), Kaoru Ueda(Jikei University School of Medicine), Chisato Saeki(Jikei University School of Medicine), Yoshihiro Matsumoto(Jikei University Kashiwa hospital), Takafumi Akasu(Jikei University Kashiwa hospital)
Cited by 14
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice
|Hepatology|1994|281
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
|Journal of Gastroenterology|2018|242
Evidence‐based clinical practice guidelines for liver cirrhosis 2020
|Hepatology Research|2021|202